Sino Medical Sciences Technology Inc.

Shanghai Stock Exchange 688108.SS

Sino Medical Sciences Technology Inc. Free Cash Flow for the year ending December 31, 2023: USD -1.53 M

Sino Medical Sciences Technology Inc. Free Cash Flow is USD -1.53 M for the year ending December 31, 2023, a 95.26% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Sino Medical Sciences Technology Inc. Free Cash Flow for the year ending December 31, 2022 was USD -32.18 M, a 6.45% change year over year.
Sino Medical Sciences Technology Inc. Free Cash Flow for the year ending December 31, 2021 was USD -34.40 M, a -431.23% change year over year.
Sino Medical Sciences Technology Inc. Free Cash Flow for the year ending December 31, 2020 was USD -6.48 M, a -6.26% change year over year.
Sino Medical Sciences Technology Inc. Free Cash Flow for the year ending December 31, 2019 was USD -6.09 M, a -3,093.92% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

Shanghai Stock Exchange: 688108.SS

Sino Medical Sciences Technology Inc.

CEO	Mr. Jianhua Sun
IPO Date	Oct. 30, 2019
Location	China
Headquarters	TEDA Biopharm Res, Building B
Employees	652
Sector	Health Care
Industries Medical Instruments Biotechnology Pharmaceuticals

Description

Sino Medical Sciences Technology Inc., a medical device company, engages in the research, development, production, and distribution of interventional devices in China. Its products include drug-eluting stents, balloon catheters, coronary stents, and transcatheter mitral valve replacement devices. Sino Medical Sciences Technology Inc. has a clinical collaboration agreement with The National University of Ireland Galway. The company was founded in 2007 and is headquartered in Tianjin, China.

Key trends

Past 5 years